— Know what they know.
Not Investment Advice

KRSA NASDAQ

Korsana Biosciences, Inc.
1W: +2.2% 1M: +3.5% 3M: +31.0% YTD: +242.1% 1Y: +115.2% 3Y: +27.0% 5Y: -92.1%
$30.07
-2.02 (-6.29%)
After Hours: $27.00 (-3.07, -10.19%)
Weekly Expected Move ±10.5%
$25 $28 $31 $35 $38
NASDAQ · Healthcare · Biotechnology · Tech Score Sell · Power 46 · $150.2M mcap · 2M float · 2.13% daily turnover · Short 36% of daily vol
Credit Risk of going bust: not rated Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
Not rated: insufficient price history.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Smart Money Score
No convergence signal
Key Statistics
Market Cap$150.2M
52W Range7.189-59.36
Volume230,499
Avg Volume35,938
Beta1.73
Dividend—
Analyst Ratings
2 Buy 0 Hold 0 Sell
Consensus Buy
Company Info
CEOJonathan Violin
Employees19
SectorHealthcare
IndustryBiotechnology
IPO Date2026-09-09
221 Crescent Street
Waltham, MA 02453
US
About Korsana Biosciences, Inc.

Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.

Recent Insider Trades

NameTypeSharesPriceDate
Pernice Michelle Pat A-Award 48,445 $26.20 2026-09-09
Shah Nimish P A-Award 48,445 $26.20 2026-09-09
Fairmount Funds Mana A-Award 48,445 $26.20 2026-09-09
Gottesdiener Andrew A-Award 48,445 $26.20 2026-09-09
Violin Jonathan 0 — 2026-09-08

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms